BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Systematix Research Report
Shriram Finance Company Ltd.'s Q2 FY24 operating performance was better than expected with net interest income/operating profit at Rs 45.9 billion/ 34.8 billion versus our estimate of Rs 43.2 billion/ 32.5 billion, aided by strong margin expansion of 60 basis points QoQ at 8.9% and 20% YOY growth in assets under management.
Reduced liquidity buffer to three months (versus five-six months earlier) and higher growth in high yielding segments of passenger vehicle, gold loan and micro, small and medium enterprise aided in sharp increase in NIMs.
Asset quality saw marginal improvement with gross stage-III/net stage-III at 5.8%/2.8% versus 6%/3% in Q1, partially aided by higher write offs at Rs. 8.4 billion.
As a result, credit costs was higher at 2.3% versus 1.9% in Q1, leading to inline profit after tax at Rs 17.5 billion.
Outlook remain upbeat, with management increasing their AUM growth guidance to 18-20% (15% earlier), while maintaining their credit cost guidance at ~2% for FY24.
Though some moderation is expected in NIMs in H2 from current levels, as new commercial vehicle sales pick up in H2 which is a low yielding segment.
We revised our earnings estimates upwards by 2.5%/ 4% for FY24/25, as we factor in higher AUM growth.
We reiterate our 'Buy' rating on Shriram Finance, with a revised target price of Rs 2,335 (Rs 2,175 earlier), valuing it at 1.6 times FY25 book value.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

Mold-Tek Packaging Q1 Review — Pharma, Paints To Drive FY26 Growth, Says PL Capital Maintaining 'Add'


Rossari Biotech Q1 Results — HPPC, New Capacities To Drive Earnings Growth, Says DRChoksey Maintaining Buy


PepsiCo Beats Estimates Citing Strong International Growth


'Hold' Polycab Shares Maintains Nirmal Bang, Says Execution, Favorable Industry Tailwinds To Drive Growth
